SARS-CoV-2 transmission risk among National Basketball Association players, staff, and vendors exposed to individuals with positive test results after COVID-19 recovery during the 2020 regular and postseason
(Risiko einer SARS-CoV-2 Übertragung unter NBA-Spielern, Trainern und Organisatoren, die Kontakt mit Personen mit einem positiven Testergebnis nach der Genesung nach COVID-19 während der regulären und der Nachsaison 2020 hatten)
Question Do individuals who have clinically recovered from COVID-19 but continue to test positive still transmit SARS-CoV-2?
Findings In this cohort study of 3648 participants, data were collected during the resumption of the 2020 National Basketball Association season in a closed environment. Individuals who recovered clinically from COVID-19 but continued to test positive did not transmit SARS-CoV-2 to others, despite close proximity with susceptible individuals.
Meaning US Centers of Disease Control and Prevention guidelines to allow discontinuation of isolation precautions for asymptomatic individuals after 10 days from symptom onset or first reverse-transcription-polymerase chain reaction (RT-PCR) positive test result, without requiring a negative RT-PCR test result, was sufficient to prevent transmission of SARS-CoV-2 in this 2020 cohort.
Abstract
Importance Clinical data are lacking regarding the risk of viral transmission from individuals who have positive reverse-transcription-polymerase chain reaction (RT-PCR) SARS-CoV-2 test results after recovery from COVID-19.
Objective To describe case characteristics, including viral dynamics and transmission of infection, for individuals who have clinically recovered from SARS-CoV-2 infection but continued to have positive test results following discontinuation of isolation precautions.
Design, Setting, and Participants This retrospective cohort study used data collected from June 11, 2020, to October 19, 2020, as part of the National Basketball Association (NBA) closed campus occupational health program in Orlando, Florida, which required daily RT-PCR testing and ad hoc serological testing for SARS-CoV-2 IgG antibodies. Nearly 4000 NBA players, staff, and vendors participated in the NBA`s regular and postseason occupational health program in Orlando. Persistent positive cases were those who recovered from a documented SARS-CoV-2 infection, satisfied US Centers for Disease Control and Prevention criteria for discontinuation of isolation precautions, and had at least 1 postinfection positive RT-PCR test(s) result.
Exposures Person-days of participation in indoor, unmasked activities that involved direct exposure between persistent positive cases and noninfected individuals.
Main Outcomes and Measures Transmission of SARS-CoV-2 following interaction with persistent positive individuals, as measured by the number of new COVID-19 cases in the Orlando campus program.
Results Among 3648 individuals who participated, 36 (1%) were persistent positive cases, most of whom were younger than 30 years (24 [67%]) and male (34 [94%]). Antibodies were detected in 33 individuals (91.7%); all remained asymptomatic following the index persistent positive RT-PCR result. Cycle threshold values for persistent positive RT-PCR test results were typically above the Roche cobas SARS-CoV-2 limit of detection. Cases were monitored for up to 100 days (mean [SD], 51 [23.9] days), during which there were at least 1480 person-days of direct exposure activities, with no transmission events or secondary infections of SARS-CoV-2 detected (0 new cases).
Conclusions and Relevance In this retrospective cohort study of the 2020 NBA closed campus occupational health program, recovered individuals who continued to test positive for SARS-CoV-2 following discontinuation of isolation were not infectious to others. These findings support time-based US Centers of Disease Control and Prevention recommendations for ending isolation.
© Copyright 2021 JAMA Internal Medicine. Alle Rechte vorbehalten.
| Schlagworte: | |
|---|---|
| Notationen: | Spielsportarten Biowissenschaften und Sportmedizin |
| Tagging: | Coronavirus |
| Veröffentlicht in: | JAMA Internal Medicine |
| Sprache: | Englisch |
| Veröffentlicht: |
2021
|
| Online-Zugang: | https://doi.org/10.1001/jamainternmed.2021.2114 |
| Dokumentenarten: | Artikel |
| Level: | hoch |